Drug Profile
Lidocaine - Noven Pharmaceuticals
Alternative Names: DentiPatchLatest Information Update: 20 Jan 2022
Price :
$50
*
At a glance
- Originator Noven Pharmaceuticals
- Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
- Mechanism of Action Cell membrane permeability inhibitors; Opioid receptor agonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Dental pain
- No development reported Allergic rhinitis
Most Recent Events
- 27 Aug 2009 Noven Pharmaceuticals has been acquired by Hisamitsu Pharmaceutical
- 08 Oct 1999 No-Development-Reported for Allergic rhinitis in USA (Topical)
- 21 Dec 1998 Launched for Dental pain in USA (Transmucosal)